Profil
Pamela Holland worked as the Vice President of Cancer Biology at Surface Oncology, Inc. She then served as the Senior Vice President of Research at Alpine Immune Sciences, Inc. Dr. Holland holds a doctorate degree from the University of Washington and an undergraduate degree from the University of California San Diego.
Anciens postes connus de Pamela Holland
| Sociétés | Poste | Fin |
|---|---|---|
| ALPINE IMMUNE SCIENCES, INC. | Directeur Technique/Scientifique/R&D | 01/05/2023 |
| SURFACE ONCOLOGY, INC. | Corporate Officer/Principal | - |
Formation de Pamela Holland
| University of California San Diego | Undergraduate Degree |
| University of Washington | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ALPINE IMMUNE SCIENCES, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Surface Oncology, Inc.
 Surface Oncology, Inc. BiotechnologyHealth Technology Surface Oncology, Inc. operates as a clinical-stage immuno-oncology company, which engages in the provision of biological pathways critical to the immunosuppressive tumor microenvironment for the development of next-generation cancer therapies. The firm’s pipeline includes wholly-owned lead programs targeting CD39 (SRF617) and IL-27 (SRF388), as well as a preclinical program focused on depleting tumor regulatory T cells via targeting CCR8 (SRF114). Its pipeline also includes licensed product programs, such as a collaboration with Novartis targeting CD73 (NZV930, Phase 1) and a collaboration with GlaxoSmithKline targeting PVRIG (SRF813, preclinical). The company was founded by David S. Grayzel in 2014 and is headquartered in Cambridge, MA. | Health Technology |
